Literature DB >> 11285002

Autoimmune hyperthyroidism in multiple sclerosis under treatment with glatiramer acetate--a case report.

C Heesen, J Gbadamosi, B G Schoser, D Pöhlau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11285002     DOI： 10.1046/j.1468-1331.2001.00196.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  5 in total

1.  Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.

Authors:  Helmut Neumann; Antal Csepregi; Michael Sailer; Peter Malfertheiner
Journal:  J Neurol       Date:  2007-03-12       Impact factor: 4.849

2.  Risk-benefit assessment of glatiramer acetate in multiple sclerosis.

Authors:  T Ziemssen; O Neuhaus; R Hohlfeld
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.

Authors:  Naila Makhani; Bo-yee Ngan; Binita M Kamath; E Ann Yeh
Journal:  Neurology       Date:  2013-07-24       Impact factor: 9.910

4.  Acute hepatitis induced by glatiramer acetate.

Authors:  Pierre Deltenre; Marie-Odile Peny; André Dufour; Mohamed El Nady; Jean Henrion
Journal:  BMJ Case Rep       Date:  2009-02-27

5.  The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

Authors:  Alasdair J Coles; Amanda Cox; Emmanuelle Le Page; Joanne Jones; S Anand Trip; Jackie Deans; Shaun Seaman; David H Miller; Geoff Hale; Herman Waldmann; D Alastair Compston
Journal:  J Neurol       Date:  2005-07-27       Impact factor: 4.849
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.